SARS-CoV-2 Omicron is an immune escape variant with an altered cell entry pathwayBrian J. Willett, James Austin, Diego Cantoni et al.|Nature Microbiology|2022Cited by 724
SARS-CoV-2-specific nasal IgA wanes 9 months after hospitalisation with COVID-19 and is not induced by subsequent vaccinationFelicity Liew, Meera Chand, Shubha Talwar et al.|EBioMedicine|2022Cited by 121
Nasal IgA wanes 9 months after hospitalisation with COVID-19 and is not induced by subsequent vaccinationFelicity Liew, Peter Openshaw, Shubha Talwar et al.|medRxiv|2022Cited by 18